Outset Medical
152 hedge funds and large institutions have $584M invested in Outset Medical in 2023 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 51 increasing their positions, 52 reducing their positions, and 26 closing their positions.
11% more call options, than puts
Call options by funds: $1.32M | Put options by funds: $1.19M
0.02% more ownership
Funds ownership: 7.18% → 7.2% (+0.02%)
2% less repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 52
8% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 26
1% less funds holding
Funds holding: 154 → 152 (-2)
50% less capital invested
Capital invested by funds: $1.16B → $584M (-$574M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$16.5M |
| 2 |
B
Braidwell
Stamford,
Connecticut
|
+$14.8M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$9.84M |
| 4 |
GC
GMT Capital
Atlanta,
Georgia
|
+$8.51M |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$6.04M |
Top Sellers
OM Hedge Fund Activity: Q3 2023 in Review
152 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q3 2023, worth a combined $584M — down 50% from $1.16B a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of OM and 24 opened new positions — a net loss of 2 holders — while 52 trimmed existing stakes and 51 added.
The largest buyer was Morgan Stanley, adding an estimated $16.5M. The largest seller was Bellevue Group, cutting an estimated $11.3M.
- 152 institutional investors held Outset Medical (OM) as of Q3 2023, down from 154 in Q2 2023.
- Funds reported $584M of Outset Medical stock for Q3 2023, down 50% quarter-over-quarter.
- 24 funds opened new Outset Medical positions in Q3 2023 and 26 closed out, a net change of -2 holders.
- The largest Outset Medical buyer in Q3 2023 was Morgan Stanley, an estimated $16.5M added.
- The largest Outset Medical seller in Q3 2023 was Bellevue Group, an estimated $11.3M sold.
Based on aggregated 13F filings for Q3 2023.